Loading…

The DiaTrust Covid-19 IgG/IgM Rapid Test, jointly developed by Celltrion and Humasis, received FDA emergency use authorization. Celltrion USA also signed a $214.5 million supply contract with Prime Healthcare Distributors.
“DiaTrust is a product for healthcare professionals designed to recognize a specific surface antigen of the coronavirus for the diagnosis of infection within 15 minutes.”pulse.mk.co.kr
Summarized from public sources; check the original articles before acting on it.